FDA Issues Draft Guidance on Psychedelic Drug Trials FDA Issues Draft Guidance on Psychedelic Drug Trials

The guidance offers ' fundamental considerations ' for designing clinical trials testing psychedelic drugs as potential treatments psychiatric and other conditions.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Alert Source Type: news